ASX - By Stock
|
KZA |
Re:
Ann: Notification of cessation of securities - KZA
|
|
xlr82nulevels
|
54 |
12K |
15 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
54
|
12K
|
15
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
xlr82nulevels
|
791 |
218K |
3 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
791
|
218K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
xlr82nulevels
|
48 |
14K |
14 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
48
|
14K
|
14
|
|
ASX - By Stock
|
KZA |
Re:
SNO 26th Annual Meeting
|
|
xlr82nulevels
|
123 |
36K |
9 |
09/10/21 |
09/10/21 |
ASX - By Stock
|
123
|
36K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
How does GBM AGILE work?
|
|
xlr82nulevels
|
73 |
24K |
13 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
73
|
24K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
No Insight
|
|
xlr82nulevels
|
94 |
23K |
11 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
94
|
23K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
xlr82nulevels
|
559 |
155K |
15 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
559
|
155K
|
15
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
620K |
11 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
2.0K
|
620K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia licenses EVT801 from Evotec
|
|
xlr82nulevels
|
36 |
11K |
2 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
36
|
11K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents PK data for paxalisib at AACR meeting
|
|
xlr82nulevels
|
17 |
6.3K |
15 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
17
|
6.3K
|
15
|
|
ASX - By Stock
|
KZA |
Re:
Congratulations
|
|
xlr82nulevels
|
29 |
9.8K |
11 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
29
|
9.8K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
620K |
9 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
2.0K
|
620K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Dr Priscilla Brastianos
|
|
xlr82nulevels
|
186 |
66K |
5 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
186
|
66K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
620K |
8 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
2.0K
|
620K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Market Cap
|
|
xlr82nulevels
|
41 |
6.3K |
0 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
41
|
6.3K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Market Cap
|
|
xlr82nulevels
|
41 |
6.3K |
5 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
41
|
6.3K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Therapeutics investor briefing
|
|
xlr82nulevels
|
7 |
2.0K |
6 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
7
|
2.0K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
xlr82nulevels
|
102 |
19K |
4 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
102
|
19K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Notice of Extraordinary General Meeting/Proxy Form
|
|
xlr82nulevels
|
100 |
25K |
2 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
100
|
25K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Dr Priscilla Brastianos
|
|
xlr82nulevels
|
186 |
66K |
14 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
186
|
66K
|
14
|
|
ASX - By Stock
|
KZA |
Re:
Dr Priscilla Brastianos
|
|
xlr82nulevels
|
186 |
66K |
4 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
186
|
66K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Dr Priscilla Brastianos
|
|
xlr82nulevels
|
186 |
66K |
15 |
27/09/20 |
27/09/20 |
ASX - By Stock
|
186
|
66K
|
15
|
|
ASX - By Stock
|
KZA |
Re:
Paxalisib GBM Interim data Abstract at SNO Virtual 19-21 November 2020
|
|
xlr82nulevels
|
27 |
7.1K |
9 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
27
|
7.1K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
OS, PFS, QOL
|
|
xlr82nulevels
|
20 |
5.4K |
5 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
20
|
5.4K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Interview with Dr Matt Dun on DIPG research and GDC-0084
|
|
xlr82nulevels
|
81 |
24K |
7 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
81
|
24K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
620K |
7 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
2.0K
|
620K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib awarded Orphan Drug Designation
|
|
xlr82nulevels
|
19 |
7.8K |
13 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
19
|
7.8K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
xlr82nulevels
|
22 |
6.8K |
6 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
22
|
6.8K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
620K |
3 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
2.0K
|
620K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib obtains Rare Pediatric Disease Designation
|
|
xlr82nulevels
|
102 |
33K |
3 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
102
|
33K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
4 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
270
|
75K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Kza
|
|
xlr82nulevels
|
73 |
22K |
9 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
73
|
22K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
xlr82nulevels
|
16 |
3.6K |
4 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
16
|
3.6K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
3 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
270
|
75K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
4 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
270
|
75K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
5 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
270
|
75K
|
5
|
|
ASX - By Stock
|
KZA |
St. Jude 15 wk lecture
|
|
xlr82nulevels
|
1 |
394 |
5 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
1
|
394
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
xlr82nulevels
|
559 |
155K |
3 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
559
|
155K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
2 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
270
|
75K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Stock Offering Theory
|
|
xlr82nulevels
|
10 |
3.2K |
6 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
10
|
3.2K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
10 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
270
|
75K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
8 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
270
|
75K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Price Action
|
|
xlr82nulevels
|
14 |
3.8K |
5 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
14
|
3.8K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Kza
|
|
xlr82nulevels
|
73 |
22K |
5 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
73
|
22K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
620K |
5 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
2.0K
|
620K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
xlr82nulevels
|
559 |
155K |
4 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
559
|
155K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib obtains Rare Pediatric Disease Designation
|
|
xlr82nulevels
|
102 |
33K |
3 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
102
|
33K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
7 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
270
|
75K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
xlr82nulevels
|
559 |
155K |
7 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
559
|
155K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
xlr82nulevels
|
559 |
155K |
8 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
559
|
155K
|
8
|
|